David S. Utley, M.D.
President & CEO
Dr. Utley graduated from Harvard Medical School (’92) and completed his surgical training in otolaryngology-head and neck surgery, as well as facial plastic and reconstructive surgery, at Stanford University Medical Center, where he was subsequently appointed to the faculty as clinical assistant professor of surgery (1992-2003). He has over 25 peer-reviewed publications related to GI, plastic and reconstructive surgery, and otolaryngology.
Prior to starting Carrot, Utley was the first employee and Chief Medical Officer for BARRX Medical (GI endoscopy, acquired by Covidien in 2012) from 2003 to 2014.
Utley has had additional roles as founder, chief medical officer, or member of the board of directors with several start-up medical device companies, including: Somnus Medical Technologies (ENT), Curon Medical (GI), Aetherworks (pulmonary), BAROnova (GI), Freedom-2 (plastics), and CoAlign Innovations (spine), and is the inventor on more than 65 issued U.S. patents and 100 published U.S. patents.
Dan is a seasoned executive with over 30 years of medical device experience, who has worked in small entrepreneurial companies, as well as Fortune 500 corporations.
Dan recently held C-level positions at DFINE, Inc. as Chief Development Officer until it’s acquisition in July of 2016 and prior to DFINE, as the President & CEO, and member of the Board of Directors, of BaroSense, Inc., a company focused on minimally invasive devices for the treatment of obesity.
Early in his career Dan held various senior management and engineering roles at Rita Medical (successful IPO in August 2000), Johnsons & Johnson Medical Inc., VA (as world-wide Director of R&D), Menlo Care (acquired by J&J in May of 1995) and American Pharmaseal.
Dan currently sits on the Board of Directors for BAROnova, a clinical-stage medical-technology company developing endoscopically-delivered devices for the chronic treatment of obesity.
Dan holds a BSME from California Polytechnic State University and is the author of over 120 patents or patent applications in the medical device field.
Sr. Director, Marketing & Content
John is a longtime journalist, media executive, and marketer who holds a BA from the University of Florida and an MS, Journalism, from Columbia University. He has served in leadership positions at Wired, Outside, “the Japan News,” Penton, the Competitor Group. Additionally, John has written for the New York Times Magazine, Popular Science, and NBC, among others. His work has focused primarily on health sciences and consumer technology, but it has ranged from sumo wrestling to theoretical physics.
In addition to his media career, John has worked in marketing as a designer and copywriter, in both the U.S. and Japan, having done work for multinationals like Dentsu, Sony, and Merrill Lynch. He also mentors social entrepreneurs on communications and marketing strategy and helped launch the media operation for the Unreasonable Group, a platform for incubating, funding, and promoting social entrepreneurs around the world.
John joined Carrot’s advisory board in 2015. A year later, he joined the full-time staff to help develop the voice of Pivot, build out marketing operations, and manage content creation across various teams.
Sr. VP, Marketing & Business Development
Rachel has over 17 years of experience developing advanced products for obesity surgery, gastroenterology, and ENT at companies including Xlumena, J&J/Acclarent, and Satiety, Inc.
She has managed development of both products and ancillary services for use by both doctors and patients, including implementation of evidence-based behavior modification programs for patients undergoing bariatric surgery.
Her roles have included strategic marketing including defining user needs for products and guiding development teams to deliver such products, planning and executing product launches, and pursuing reimbursement for medical products and services in U.S. and international payment environments.
Prior to joining the health care industry, Rachel spent five years in healthcare investment banking in San Francisco and New York. Rachel has a degree in Industrial Engineering from Stanford and an MBA from the Wharton School.
Sr. VP, Client Success
Debi has more than 25 years of experience in the health management and wellness industry and has held positions with many of the leading vendors in the space, including StayWell, Health Media, Alere, Healthyroads, and Aon. She has successfully led large client management teams in efforts such as implementation, program strategy, and day-to-day program management. At Carrot, Debi leads the client success team, ensuring customer satisfaction from the sales process through the lifecycle of the client relationship.
Prior to joining Carrot, Debi spent seven years as the senior vice president of program solutions and client strategy at Healthyroads, where she lead a client management team, helped with ongoing product development, managed the consumer health team, and was the executive sponsor for all strategic accounts, including many Fortune 500 groups.
Debi is passionate about employee well-being and has spoken frequently on the topic over the year, including at the Conference Board and the Benefits & Wellness Forum.
Debi holds a bachelor’s in community health education from the University of Northern Iowa and Master’s in wellness from Ball State University.
VP, Design & Experience
Grace brings two decades of experience helping companies leverage design to differentiate and bring meaningful products and services to market. She is incredibly passionate about finding the intersection between what matters to people and how technology can help deliver it.
Prior to Carrot, Grace spent 12 years at the global innovation consultancy IDEO. There, she led multidisciplinary teams and collaborated with startups, nonprofit organizations, and Fortune 500 companies like Samsung, NASA, AARP, and ConAgra. She helped them innovate and transform through rapid prototyping and insight-driven design, and by building the capacity to implement despite ambiguity.
Grace co-led IDEO’s Food and Beverage practice and served as Executive Director of IDEO’s Design for Health practice. She holds multiple patents and was awarded Fast Company’s Innovation By Design Award for her work on the patient and employee experience for Planned Parenthood.
Grace holds B.S. degrees in both mechanical engineering and product design from Stanford University. An interaction designer by trade, she continues to merge her experience in both hardware and software. She also remains active at her alma mater, as an instructor of both undergraduate and graduate-level courses focused on using the design process to explore human connection in healthcare delivery.
Ha Van T. Le
Sr. Director, Finance
Ha Van T. Le has more than 20 years of experience in budgeting, finance, and accounting for the high-tech industry, with an emphasis in business enterprise solutions and business intelligence.
Throughout her career, Ha Van has participated in multiple acquisitions and two successful initial public offerings: Accuray, Inc. in 2007 and Valicert, Inc. in 2000.
In 2003, Valicert merged with Tumbleweed Communications (NASDAQ: TMWD).
Prior to joining Carrot, Ha Van was the Corporate Controller and VP, Finance and Revenue Operations, at GetInsured, where she played an integral role in the company’s success and growth from 10 to 450 employees.
Ha Van joined Carrot in November of 2017, bringing an in-depth and a wide array of experience and expertise in Finance Operations. As Carrot’s Senior Director, Finance, she is responsible for all aspects of the company’s financial management.
Ha Van holds an MBA from San Jose State University of California and a BS in Managerial Economics from the University of California, Davis.
Jennifer Marler, M.D.
Sr. Director, Clinical Affairs
Dr. Marler received her BS in Neuroscience from UCLA, graduated from the Medical College of Virginia and trained in Radiology at the University of Virginia.
Prior to joining Carrot, she served as the Sr. Director of Global Medical Affairs for BARRX Medical (GI endoscopy, acquired by Covidien in 2012) from 2008 to 2015.
She had increasing roles of responsibility while at BARRX Medical and Covidien, ultimately managing the Medical Affairs team with oversight of the clinical evidence-based strategy, peer relationships, clinical education, and medical writing along with collaborative leadership in clinical trial design, reimbursement and regulatory strategy.
VP, Customer Collaboration & Strategy
Prior to joining Carrot as V.P, Customer Collaboration and Strategy, Joe Mongelli spent over 25 years in employee benefits consulting and 8 years managing the global benefits function at Covidien, which was acquired by Medtronic in 2015.
Joe joined Covidien in 2007 prior to its spin out from Tyco International into a world-leading, independent medical devices and supplies company. At Covidien, Joe was the leader of the global benefits function with responsibility for the benefits of 40,000 employees in more than 50 countries. Joe and his team studied the health and financial risks among employees and used innovative tactics to successfully engage employees to better understand their health status, take steps to improve their well-being and to be more fit. When Medtronic acquired Covidien, Joe co-led benefits transition projects in the U.S., Latin America, Japan and the U.K as the two companies joined to form a global workforce of more 80,000 employees.
Prior to Covidien, Joe spent 25 years in benefits consulting, 18 of which were with Towers Perrin in Boston. In his role as a Principal (partner) at Towers Perrin, he managed major client relationships in health care and higher education industries, was the national practice leader for the higher education industry and a member of the Boston office management team.
Joe served as President of the New England Employee Benefits Council (NEEBC) for two years and has been a member of its Board of Directors for 12 years. He is a frequent speaker at NEEBC seminars.
Joe holds a Bachelor of Science degree magna cum laude from New York University and a Master of Music degree from Manhattan School of Music.
Scott has over 16 years of experience as a senior executive in healthcare technology companies that have transformed the distribution of healthcare services and connected millions of consumers with affordable healthcare. At Carrot, Scott oversees sales for our flagship product, Pivot.
Prior to Carrot, Scott led B2C and B2B sales and business development at GoHealth and GetInsured taking both early-stage companies to scale. Scott’s efforts have amassed a portfolio of enterprise SaaS clients across government, employer and health plan markets.
Scott has been a frequent speaker and panelist at industry events including Health 2.0, AHIP, Employer Benefit News Expo, The Institute for Healthcare Consumerism, the World Congress Private and Public Exchange Summit, and more. He holds a BA in Marketing from Miami University.
Sr. Director, Talent & Culture
Desiree has been building and supporting great teams for over 18 years. Her people career began in the medical device industry, where she focused on creating and driving talent-management programs.
After 12 years in the startup world, she joined the Permanente Medical Group, where she served as the single point of contact and subject-matter expert in all matters related to people strategy, team performance, conflict resolution approaches, leadership coaching, and employee engagement for physician staff.
She joined the Carrot team in January of 2017. Her mission is to create and maintain a culture of engagement and execution capabilities through attracting, supporting, and retaining motivated and engaged team members (also known as “Carrots”).
Desiree holds undergraduate degrees in economics and legal studies and a Master of Clinical Psychology from CIIS in San Francisco.
Heather Patrick, Ph.D
VP, Behavioral Science
Dr. Patrick earned her Ph.D. in Social Psychology in 2003 from the University of Houston and has served on the faculty at Baylor College of Medicine (2004–’06) and the University of Rochester (2006–’09). From 2009 to 2014, she was a health scientist and program director at the National Cancer Institute, and the associate director of the SmokeFree.gov Initiative.
Prior to coming to Carrot, Dr. Patrick was the principal behavioral scientist and senior director of applied behavior change science at Envolve PeopleCare (EPC). In that role, she was responsible for ensuring the rigorous application of behavioral science to EPC’s portfolio of programs in digital health, health coaching, and behavioral health case management, offered in both health plan and corporate wellness markets.
Dr. Patrick has more than 50 peer-reviewed publications and nearly 15 years of experience using scientific theories of human motivation to develop, implement, and evaluate behavioral interventions in tobacco cessation, nutrition, weight management, physical activity, and stress management.
Dennis has spent his entire 15-plus-year career in the software industry, in various leadership positions. At Carrot, he oversees Software Engineering, IT, and R&D.
Prior to joining Carrot, Dennis was CTO of Indochino, where he helped scale the company from e-commerce startup to an organization with millions of dollars in monthly revenue and retail stores across North America. He was also previously Director of Technology for CBS Interactive Music Group and the founder of Xian Software, whose clients included CBS and Kobo Books.
Dennis holds a Bachelor of Mathematics, with Honors, in Computer Science from the University of Waterloo.
Rajiv has worked in and advised Fortune 500 companies and startups over a 20-year career as a product leader. He brings a blend of strategic and operational expertise to develop products that delight users and achieve results.
Prior to joining Carrot, Rajiv spent more than seven years in digital media as a product management leader at Yahoo, Flickr, and Imgur, where he led a variety of initiatives to drive growth, monetization, and user engagement across both native app and web experiences. He also spent more than three years as a strategy consultant where he advised technology and health care companies on revenue growth, with a focus onproduct growth and innovation.
Rajiv started his career at Intel Corporation, where he held a variety of engineering and leadership roles in manufacturing semiconductor products. He holds an MBA from Berkeley and BS/MS degrees from Columbia University.
Judith (Jodi) Prochaska, Ph.D, MPH
Chair, Advisory Board, Associate Professor, Medicine Stanford Prevention Research Center
Judith (Jodi) Prochaska, PhD, MPH is Associate Professor of Medicine with the Stanford Prevention Research Center and a member of the Stanford Cancer Institute. Dr. Prochaska is a Principal Investigator on multiple research awards from the National Institutes of Health and the State of California Tobacco-Related Disease Research Program. Her research program is leveraging technology (e.g., web, text, social media) to bring tobacco cessation treatment into novel settings and to populations with high smoking prevalence. With attention to medical education and clinical practice, Dr. Prochaska has disseminated tobacco treatment curricula as part of Rx for Change (http://rxforchange.ucsf.edu). She has authored 175 peer-reviewed publications, serves on the Editorial Board of JAMA Internal Medicine, and is on the advisory board for Optum’s Quit for Life Tobacco Quitline. Dr. Prochaska is President of the Society for Research on Nicotine and Tobacco (SRNT), the international scientific society aimed at stimulating the generation and dissemination of new knowledge concerning nicotine and tobacco from bench to bedside and through to health policy.
Carla J. Berg, PhD
Associate Professor, Behavioral Sciences and Health Education Emory University
Carla J. Berg, PhD is an Associate Professor in the Department of Behavioral Sciences and Health Education in Emory University’s Rollins School of Public Health and the Associate Director of Population Sciences at Emory’s Winship Cancer Institute.
Dr. Berg received her Ph.D. in clinical health psychology from the University of Kansas, completed her residency training at Massachusetts General Hospital/Harvard Medical School in behavioral medicine, and then completed her postdoctoral training at the University of Minnesota in the Department of Medicine. She joined the faculty at Emory University in 2009 from the University of Minnesota. She is currently pursuing her MBA in Emory’s Goizueta Business School.
Dr. Berg’s research primarily focuses on tobacco control, with particular emphases on health disparities, policy change and impact, social marketing, consumer behavior, and vulnerable populations (e.g., youth, minorities). She has conducted NIH-funded research domestically focusing on youth tobacco use and prevention as well as comorbidities including alcohol and marijuana use within the context of diverse policy and market environments. Her work in alternative tobacco products, particularly e-cigarettes, as well as for her work in tobacco-marijuana co-use is well-known. She also received a Fulbright Scholarship in 2013 to conduct tobacco control research in the Republic of Georgia; she has worked internationally in China, India, and elsewhere as well. Dr. Berg also is working in the area of improving quality of life among cancer survivors through the use of positive psychology. To address these research areas, Dr. Berg’s methodological strengths include developing and testing interventions involving technology-based approaches, behavioral counseling, and pharmacotherapy; conducting longitudinal studies; survey research; and qualitative research.
Dr. Berg’s research has been funded by the National Cancer Institute, Centers for Disease Control, ClearWay Minnesota, and several others. She has published over 145 peer-reviewed journal articles and 3 books/book chapters in her areas of expertise. Her articles have been published in a number of leading journals including Preventive Medicine, American Journal of Preventive Medicine, American Journal of Public Health, Tobacco Control, Nicotine and Tobacco Research, Psycho-oncology, Journal of Cancer Survivorship, and Cancer Epidemiology, Biomarkers and Prevention. Dr. Berg has been honored with multiple national awards in research, including awards from the Society for Research on Nicotine and Tobacco, the American Psychological Association, and the American Association for Cancer Research.
Dr. Berg has been a member of SRNT since 2004. She has attended each annual meeting since then, has served as an abstract reviewer each year, has been a member of the Membership Committee, and has been involved in several networks including the Global Health Network within which she has served as co-chair since 2014, as well as the Health Disparities, Treatment, and Public Policy Networks. She is eager to continue serving SRNT and its mission.
Judith S. Gordon, Ph.D
Professor, Medicine University of Arizona
Judith S. Gordon, Ph.D., is Executive Director of Research Initiatives in the College of Nursing. She is a Professor in the Division of Community and Systems Health and the Department of Family and Community Medicine at the University of Arizona. She received her doctorate degree in Clinical Psychology from the University of Oregon.
Dr. Gordon has over 20 years of experience in the conduct of tobacco cessation and tobacco use prevention research. Her current interests focus on the use of technology for promoting tobacco cessation both in healthcare settings and direct-to-consumer applications. Dr. Gordon’s areas of expertise include:
Dr. Gordon has been the PI or Co-Investigator on more than 30 projects funded by the National Institutes of Health, the Department of Defense, and private foundations. She has authored and co-authored numerous publications in peer-reviewed journals, and presented widely at national and international scientific conferences. Dr. Gordon served on many proposal review committees, editorial boards, and professional societies.
Sharon Hall, Ph.D.
Professor, Psychiatry UCSF
Dr. Sharon Hall is Professor Emeritus on Recall in the Department of Psychiatry at the University of California, San Francisco (UCSF). Her research focuses on the treatment of tobacco dependence and better understanding of the processes of change through randomized clinical trials and related studies.
She has special expertise in the successful development of interventions for smokers with physical and mental co-morbidities and on intensive and extended interventions. A major theme of her work has been the integration of behavioral treatment with pharmacological interventions. She was the founder and Director of the UCSF Habit Abatement Clinic. The Clinic has treated approximately 3,000 smokers using innovative methods. In recognition of her contributions to the science of the treatment of tobacco dependence, she was awarded the Ove Fernö Award for Clinical Research by the Society for Research on Nicotine and Tobacco.
She directed a NIH-funded Center Grant, “Treatment of Complex Patients” and a related postdoctoral training program in drug abuse treatment and services research, and is active in mentoring students, trainees and junior scientists. She received the George Sarlo Prize for Teaching and Mentoring from the Department of Psychiatry at UCSF.
Her public service activities include service on numerous national and state research review committees.
Dr. Hall is a licensed psychologist in the State of California.
Danielle Ramo, Ph.D.
Director of Research Operations, Hopelab
Dr. Danielle Ramo is a licensed clinical psychologist and Director of Research Operations at Hopelab, a social innovation lab making digital tools to support adolescent health and emotional well-being. She is also Adjunct Associate Professor in the Department of Psychiatry and the Helen Diller Family Comprehensive Cancer Center at UC San Francisco, where she conducts research at the intersection of teen substance use and digital health.
Dr. Ramo came to Hopelab after six years on the faculty of UCSF’s Department of Psychiatry. She has led multiple clinical trials testing the efficacy of social media-mediated treatment to reduce substance use, as well as studies examining the toxicology of vaping in adolescents and tobacco and marijuana co-use in a changing policy landscape. Dr. Ramo has published more than 65 peer-reviewed papers and multiple book chapters in the areas of substance use and mental health among young people, and she has received grants from the National Institute on Drug Abuse, the National Institute on Minority Health and Health Disparities, and the California Tobacco-Related Diseases Research Program.
In addition to her work with Carrot, Dr. Ramo serves on the Scientific Advisory Board of the Being Adept prevention intervention program and regularly speaks to teens, parents, and school administrators throughout the Bay Area about adolescent substance abuse. She obtained a Bachelor of Arts from Columbia University; doctoral training at the University of California, San Diego, and San Diego State University; and postdoctoral training in the Department of Psychiatry at UCSF.
For more information: danielleramophd.com
Nancy Rigotti, M.D.
Professor, Medicine Harvard Medical School
Dr. Rigotti is a Professor of Medicine at Harvard Medical School and Director of the Tobacco Research and Treatment Center at Massachusetts General Hospital, Boston, MA. She is a Past President of the Society for Research in Nicotine and Tobacco. Her research focuses on reducing the health burden of tobacco use, with a special focus on interventions for health care systems.
Nicholas J. Shaheen, M.D., MPH
Professor, Medicine and Epidemiology UNC Chapel Hill
Nicholas J. Shaheen, MD, MPH is the Bozymski-Heizer Distinguished Professor of Medicine at the University of North Carolina School of Medicine, and Chief of the Division of Gastroenterology and Hepatology at UNC. Dr. Shaheen is a methodologist in clinical trials, and has served as principal investigator on multiple large multicenter, multinational trials. Clinically, he is a recognized expert in esophageal diseases. His research and clinical interests center on gastroesophageal reflux disease, and pre-cancerous and cancerous conditions of the esophagus. He has authored greater than 300 publications in these areas. He has served as senior associate editor for the American Journal of Gastroenterology, and on multiple other editorial boards. Dr. Shaheen receives research funding from the National Institutes of Health, multiple societies, and private and public foundations.
Maxine L. Stitzer, Ph.D.
Professor of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine
Dr. Stitzer is a founding faculty member of the Behavioral Pharmacology Research Unit, a nationally recognized extramural substance abuse research laboratory within the Department of Psychiatry at Johns Hopkins University School of Medicine. Her research interests have focused on both pharmacological and behavioral approaches to the treatment of substance use disorders including opioid, stimulant and tobacco use disorders. She is perhaps best known for her pioneering and continuing work on Contingency Management in substance abuse treatment, an approach designed to enhance motivation for positive behavior change. She has continuously sustained a productive grant-supported research program, published over 280 scientific papers, co-edited a book on methadone treatment, served on the AHRQ Smoking Cessation Clinical Guidelines panel and been the recipient of numerous awards for outstanding contributions to research on substance use disorders. She currently heads the Mid Atlantic Node of the National Institute on Drug Abuse Clinical Trials Network (CTN), a project that conducts multi-site clinical trials testing the effectiveness of substance abuse treatments implemented in either specialty or medical care settings. Her interests continue to be focused on advancing the understanding of substance use disorders broadly and promoting adoption of evidence-based treatments into clinical practice.
Janice Tsoh, PhD
Professor, Psychiatry UCSF
Janice Tsoh, PhD, is a Professor of Psychiatry at the University of California San Francisco, School of Medicine. Dr. Tsoh’s research program has focused on reducing health disparities, particularly in tobacco cessation treatment targeting vulnerable populations. Dr. Tsoh’s current research is funded by the National Institutes on Health and the California Tobacco-Related Disease Research Program, which targets tobacco use and health promotion among Asian Americans. She has served as Principal Investigator on more than a dozen of clinical trials. Dr. Tsoh has extensive experience in developing and testing interactive computerized tailored intervention programs such as the “Pathways-to-Change Expert System” and “Video Doctor” in both clinical and community settings. Dr. Tsoh’s research program targets hard-to-reach populations by the use of family and peer social networks, and digital health technology to engage individuals in changing their health behaviors. Dr. Tsoh has specialties in questionnaire design, qualitative methods, intervention development, clinical research methodology, and treatment outcome evaluation in practice-based and community settings.
Samir Kaul is a founding general partner at Khosla Ventures. He is a leading investor in Impossible Foods, Oscar, EtaGen, Guardant and View, among many others. A number of his investments have achieved significant results including NanoH20 [acquired by LG Chem], Satki3 [acquired by Dyson] and Climate Corp [acquired by Monsanto]. Prior to entering the venture capital industry, Samir was a researcher at TIGR (The Institute for Genomic Research) where he co-authored a number of papers in Nature, Science and PNAS. Samir holds a bachelor’s degree in biology from the University of Michigan. He also studied biochemistry at the University of Maryland. He holds a master’s degree in business administration from Harvard University.
John C. “Jack” Stoddard
Independent Board Member
Jack Stoddard has over 25 years of digital healthcare experience. He served as the founding Chief Operating Officer and Chief Strategy Officer of Accolade, a healthcare technology and services company backed by Andreesen Horowitz, Comcast Ventures, and McKesson Ventures. Prior to Accolade, Jack was part of part of the executive team which created Optum within UnitedHealth Group where he served as the Senior Vice President of Employer Solutions. Prior to Optum, Jack was an executive at Health Dialog and The Advisory Board Company. Jack holds an MBA from Harvard Business School and earned his Bachelor’s degree at Denison University with highest honors. Jack currently serves on the board of directors of Novasom, a private health technology company backed by TPG, Safeguard, and Quaker Bio. He also serves on the Board of Trustees of the Philadelphia Outward Bound School. He is an advisor to Devoted Health, a start-up Medicare Advantage Plan backed by Venrock, Oak HC/FT, and Maverick. He also serves as an Operating Executive for New Mountain Capital supporting their healthcare investments. His interests, shared by his wife, Alicia, his daughter, Allie, and son, Jackson, all center on healthy, outdoor family activities including skiing, golf, backpacking, fly fishing, and travel. He is a native of Colorado and currently lives in Philadelphia, PA.
VP, Consumer Venture Investments and External Innovation, Johnson & Johnson Innovation
Stacy is Vice President of Consumer Venture Investments and External Innovation with Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and is based in California.
Stacy leads consumer and health technology venture investing and is responsible for all equity investments across the Consumer global franchises, as well as enterprise areas that include Health and Wellness Solutions and Health Technology.
Stacy has nearly two decades of diverse experience in the healthcare, life sciences and consumer sectors as a transactional attorney, business development executive, venture investor and business strategist.
Previously, Stacy was a partner at Physic Ventures, a venture capital firm investing in health and sustainability, where she led investments in personalized health solutions that empower consumers to improve their health and wellbeing. Stacy has also been active in the design and execution of science-enabled innovation strategies, business incubation and spin-off opportunities, advising senior management of global enterprises in the CPG industry, as well as pre-commercial and commercial-stage companies in the personalized health and medical technology sectors.
Prior to joining Physic Ventures, Stacy held leadership positions in the business development groups at Genentech and Third Wave Technologies and was a technology transactions attorney at Wilson, Sonsini, Goodrich & Rosati. Stacy serves as an advisor on the Springboard Enterprises Life Sciences Council and to the UCSF Clinical and Translational Research Institute T1 Catalyst Program.
Stacy earned her B.A. in Sociology from the University of Pennsylvania and received her J.D. from Vanderbilt Law School.